Snake Bites
10
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
10.0%
1 terminated out of 10 trials
85.7%
-0.8% vs benchmark
30%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Analysis of the Efficacy of Pressure Pad vs Pressure Bandage Immobilisation for Snake Bite First Aid in Healthy Volunteers.
Evaluation of Anti-venoms Serum in Africa
Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite
Safety and Effectiveness of PANAF-Premium TM Snake Venom Antiserum As Standard Treatment for Snakebites
Hemostatic Variables In Snakebite Study
Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom.
Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
Non-inferiority Trial of Two Snake Antivenoms in CAR (PAVES)
Improving Safety of Antivenom in People Bitten by Snakes